Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Virtual Cognitive Behavioural Therapy for Psychosis [NA]
This ClinicalTrials.gov entry notes a completed study evaluating virtual cognitive behavioural therapy for psychosis in individuals with psy…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating the safety and tolerability of CVL-231 (emraclidine) in adul…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment [NA]
A clinical trial is investigating alternative stimulation modes and locations for auditory hallucination neuromodulation in schizophrenia. T…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations [NA]
An ongoing clinical trial assessing maintenance rTMS for auditory verbal hallucinations in schizophrenia/psychosis; recruitment is currently…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Effects of RAS in SZ [NA]
Clinical trial update for a study evaluating the effects of RAS in schizophrenia and schizoaffective disorder. The trial status is NOT_YET_R…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-24FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for haloperidol decanoate from NorthStar RxLLC.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: tACS to Improve Negative Symptoms & Cognition in Long-term Hospitalized Schizophrenia Patients. [NA]
Clinical trial update on using transcranial alternating current stimulation (tACS) to improve negative symptoms and cognition in long-term h…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease [NA]
A recruiting clinical trial led by Hôpital le Vinatier examining neurofilament light chains and cognitive impairment in chronic psychiatric …
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen [NA]
Clinical trial status update on a study evaluating transcranial alternating current stimulation with pre-cognitive behavioral therapy for ps…
-
FDA approval · 2025-07-23FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental ANDA for Lurasidone hydrochloride, enabling a generic version to be marketed in the U.S. L…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: BXCL501 for Agitation in Schizophrenia [Phase 1]
Phase 1 study of BXCL501 for agitation in schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Exploring the Health Effects of Group Game-based Activities on Individuals With Chronic Mental Illness [NA]
A completed clinical trial examined the health effects of group game-based activities in individuals with mental health conditions, includin…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Mindfulness-Based Education for Caregivers of Individuals Diagnosis With Schizophrenia [NA]
Completed clinical trial evaluating mindfulness-based education for caregivers of people with schizophrenia, focusing on mindfulness-related…
-
CLINICAL_TRIALS withdrawal · 2025-07-22Clinical Trial Update: Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients [NA]
The clinical trial investigating an online therapeutic tabletop game for early-onset schizophrenia has been withdrawn; no study results are …
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia [NA]
This clinical trial update notes that a study examining intermittent theta-burst stimulation as a treatment to improve negative symptoms and…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Exploratory Study of a Digital Therapeutics in People With Schizophrenia [NA]
Exploratory clinical trial of a Click Therapeutics digital therapeutic in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia [NA]
A clinical trial investigating a gamified, narrative-based intervention to improve medication adherence in schizophrenia has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trials evaluating approaches to reduce hippocampal hyperactivity and improve cognition in schizophrenia have co…
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia [Phase 2]
A Phase 2 clinical trial of vildagliptin for treating antipsychotic-induced dyslipidemia in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia [NA]
This clinical trial investigates whether a brief initial psychoeducation program improves therapeutic alliance in patients with early schizo…
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of NBI-1117568 in adults with schizophrenia has c…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Exercise and Olanzapine-samidorphan [Phase 4]
A Phase 4 clinical trial is evaluating exercise in combination with olanzapine-samidorphan for schizophrenia and related disorders, includin…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Effectiveness of A Stigma Directed Interventional Program in Schizophrenia [NA]
The trial update reports completion of a clinical trial evaluating the effectiveness of a stigma-directed interventional program for individ…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia [NA]
A completed clinical trial evaluating hedonic capacity and psychosocial interventions and their outcomes in people with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
This clinical trial update reports a real-life assessment of Abilify Maintena (aripiprazole long-acting injectable) plus Rexulti (brexpipraz…